Evidence map›Paper›PMID 26498929›Full record

ArticleBMC microbiology2015

Quinolone resistance mutations in the faecal microbiota of Swedish travellers to India.

Anna Johnning, Erik Kristiansson, Martin Angelin, Nachiket Marathe, Yogesh S Shouche, Anders Johansson, D G Joakim Larsson

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Multi-drug-resistant Escherichia coli in adult male patients with enlarged prostate attending general hospitals in Benue state.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Article
  6. Review
  7. Prevalence and characteristics of ST131 clone among unselected clinicalAntimicrobial resistance and infection control · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Anna JohnningDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10, SE-413 46, Gothenburg, Sweden. anna.johnning@chalmers.se.
Erik KristianssonDepartment of Mathematical Sciences, Chalmers University of Technology, SE-412 96, Gothenburg, Sweden. erik.kristiansson@chalmers.se.
Martin AngelinDepartment of Clinical Microbiology, Infectious Diseases, Umeå University, SE-901 85, Umeå, Sweden. martin.angelin@umu.se.
Nachiket MaratheDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10, SE-413 46, Gothenburg, Sweden. marathenachiket@gmail.com.
Yogesh S ShoucheMicrobial Culture Collection, National Centre for Cell Science, Ganeshkhind, Pune, 411 007, India. yogesh.shouche@gmail.com.
Anders JohanssonLaboratory for Molecular Infection Medicine Sweden, Department of Clinical Microbiology, Bacteriology, Umeå University, SE- 901 87, Umeå, Sweden. anders.f.johansson@umu.se.
D G Joakim LarssonDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10, SE-413 46, Gothenburg, Sweden. joakim.larsson@fysiologi.gu.se.
Chalmers University of Technology · SENational Centre for Cell Science · INUmeå University · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInternational travel contributes to the spread of antibiotic resistant bacteria over the world. Most studies addressing travel-related changes in the faecal flora have focused on specific mobile resistance genes, or depended on culturing of individual bacterial isolates. Antibiotic resistance can, however, also spread via travellers colonized by bacteria carrying chromosomal antibiotic resistance mutations, but this has received little attention so far. Here we aimed at exploring the abundance of chromosomal quinolone resistance mutations in Escherichia communities residing in the gut of Swedish travellers, and to determine potential changes after visiting India. Sweden is a country with a comparably low degree of quinolone use and quinolone resistance, whereas the opposite is true for India.

methodsMassively parallel amplicon sequencing targeting the quinolone-resistance determining region of gyrA and parC was applied to total DNA extracted from faecal samples. Paired samples were collected from 12 Swedish medical students before and after a 4-15 week visit to India. Twelve Indian residents were included for additional comparisons. Methods known resistance mutations were common in Swedes before travel as well as in Indians, with a trend for all mutations to be more common in the Indian sub group. There was a significant increase in the abundance of the most common amino acid substitution in GyrA (S83L, from 44 to 72%, p=0.036) in the samples collected after return to Sweden. No other substitution, including others commonly associated with quinolone resistance (D87N in GyrA, S80I in ParC) changed significantly. The number of distinct genotypes encoded in each traveller was significantly reduced after their visit to India for both GyrA (p=0.0020) and ParC (p=0.0051), indicating a reduced genetic diversity, similar to that found in the Indians.

conclusionsInternational travel can alter the composition of the Escherichia communities in the faecal flora, favouring bacteria carrying certain resistance mutations, and, thereby, contributes to the global spread of antibiotic resistance. A high abundance of specific mutations in Swedish travellers before visiting India is consistent with the hypothesis that these mutation have no fitness cost even in the absence of an antibiotic selection pressure.

Indexed as

Drug Resistance, BacterialMutation, MissenseTravelAdolescentAdultChildDNA GyraseDNA Topoisomerase IVEscherichiaFecesFemaleHealthy VolunteersHigh-Throughput Nucleotide SequencingHumansIndiaMaleDNA GyraseDNA Topoisomerase IVQuinolones

Identifiers

PMID26498929
PMCPMC4619388
OpenAlexW2107847506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.